At this stage, to assess in detail the clinical potential of targeted NPs, in vivo biodistribution analyses were performed in a CXCR4+ subcutaneous mouse model of patient-derived M5 colorectal cancer [21,39]. Here, CXCR4 is linked to colorectal cancer.